3-sulfanylbenzoic acid, 97.0%, 100g

4,6-Dibromobenzo[d]thiazol-2-amine, 95.0%, 5g

3,7-Bis(methylthio)dibenzo[b,d]thiophene, 97.0%, 250mg

N-(2-Chloro-4-formyl-5-methoxyphenyl)acrylamide, 95%, 1g

4-BROMO-3-CHLORO-N1-METHYLBENZENE-1,2-DIAMINE, 95%, 250mg

Condensatore di Abbe 1,25 NA con apertura per campo scuro e vetrino per contrasto di fase. Senza vetrino per campo scuro e senza vetrini per contrasto di fase

6-Methoxy-1H-indazol-5-ol, 95+%, 100mg

2-(Methyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)amino)ethanol, 97%, 5g

4-Methoxy-3-methylbenzyl chloride (stabilised with calcium carbonate), 98.0%, 25g

3-methylbicyclo[1.1.1]pentan-1-amine hydrochloride, 95.0%, 500mg

4'-Bromobenzo-18-crown 6-Ether>95.0%(GC)5g

2-Pyridin-4-ylquinoline-4-carboxylic acid, 95.0%, 1g

1-(3-methylbutanoyl)-4-piperidinecarboxylic acid, 95.0%, 1g